The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Actinogen Medical (ASX:ACW) is developing a promising oral treatment for Alzheimer’s and depression and is accelerating clinical trials with new capital.

CEO Steven Gourlay, joins The Market Online to discuss the company’s development.

Join the discussion: See what HotCopper users are saying about Actinogen Medical Ltd and be part of the conversations that move the markets.

acw by the numbers
More From The Market Online

Antipa hits 3.6Moz at Minyari in ‘significant uplift’ for gold-copper-silver project

Antipa Minerals has released a mineral resource estimate (MRE) update for the Minyari gold-copper-silver project in…

Aussie juniors leading the global natural helium hunt as supply crisis threatens

A range of Australian oil and gas juniors are hunting for critical natural helium gas supplies…

PMET hits milestone at Shaakichiuwaanaan CV5 Lithium with ESIA lodging

PMET Resources has lodged key documents for the Shaakichiuwaanaan lithium project in the James Bay region…

Prairie signs ‘monumental’ 10-year offtake deal with Korea’s Hydro for 100% of Phase One production in Saskatchewan

Prairie Lithium (ASX:PL9) has this week signed a binding definitive agreement with South Korean Hydro Lithium for the total